CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Petros Pharmaceuticals inc   (PTPI)
Other Ticker:  
 

Cumulative Petros Pharmaceuticals Inc 's Working Capital Ratio for Trailing Twelve Months Period

PTPI's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

PTPI Working Capital Ratio for Trailing Twelve Months Period

 (Sep 30 2023)
III. Quarter		 (Mar 31 2023)
I. Quarter		 (Sep 30 2022)
III. Quarter

Y / Y Current Liabilities Growth - - - - -
Y / Y Current Assets Growth - - - - -
Working Capital Ratio for Trailing Twelve Months Period 2.06 2.2 2.36 - -
Total Ranking # # # # #
Seq. Current Liabilities Growth 87.84 % -13.33 % - - -
Seq. Current Assets Growth 75.73 % -25.93 % - - -

PTPI Segments >> Back to PTPI Financial Strength Comparisons >> Compare PTPI Debt to Equity Ratio to its Competitors

Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to jump in Current Liabilities in the III. Quarter to $13 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 2.06 above Petros Pharmaceuticals Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 381 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Petros Pharmaceuticals Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about PTPI
Working Capital Ratio PTPI in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 382
Sector # 740
S&P 500 # 1883


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
0 0 0
 




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Lipella Pharmaceuticals Inc   5.65 
Bridgebio Pharma Inc   5.63 
Sarepta Therapeutics Inc   5.50 
Urogen Pharma Ltd   5.45 
Foghorn Therapeutics Inc   5.44 
Geron Corp  5.42 
Kiniksa Pharmaceuticals ltd   5.41 
Apellis Pharmaceuticals Inc   5.40 
Synlogic Inc   5.30 
Deciphera Pharmaceuticals Inc   5.26 
Legend Biotech Corporation  5.19 
Xilio Therapeutics Inc   5.18 
Arrowhead Pharmaceuticals Inc   5.16 
Protagenic Therapeutics Inc new  5.15 
Aptinyx Inc   5.12 
Ligand Pharmaceuticals Incorporated  5.08 
Bullfrog Ai Holdings Inc   5.08 
Immunic Inc   5.04 
Schrodinger Inc   5.04 
Arcus Biosciences Inc   5.01 
Y mabs Therapeutics inc   5.00 
Connect Biopharma Holdings Limited  4.99 
Trevena Inc  4.96 
Karyopharm Therapeutics Inc   4.95 
Zynerba Pharmaceuticals Inc   4.95 
Tharimmune Inc   4.91 
Cartesian Therapeutics Inc   4.91 
Bionomics Limited  4.87 
Biohaven Ltd   4.85 
Corcept Therapeutics Inc  4.81 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com